RegenETP Inc.
RegenETP, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, rep… Read more
RegenETP Inc. (RGTPQ) - Total Assets
Latest total assets as of March 2023: $18.05 Million USD
Based on the latest financial reports, RegenETP Inc. (RGTPQ) holds total assets worth $18.05 Million USD as of March 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
RegenETP Inc. - Total Assets Trend (2019–2022)
This chart illustrates how RegenETP Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
RegenETP Inc. - Asset Composition Analysis
Current Asset Composition (December 2022)
RegenETP Inc.'s total assets of $18.05 Million consist of 58.0% current assets and 42.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 50.1% |
| Accounts Receivable | $332.00K | 1.5% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $8.68 Million | 38.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2019–2022)
This chart illustrates how RegenETP Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: RegenETP Inc.'s current assets represent 58.0% of total assets in 2022, a decrease from 60.6% in 2019.
- Cash Position: Cash and equivalents constituted 50.1% of total assets in 2022, up from 19.1% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 1.0% in 2019.
- Asset Diversification: The largest asset category is property, plant & equipment at 38.0% of total assets.
RegenETP Inc. Competitors by Total Assets
Key competitors of RegenETP Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
RegenETP Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - RegenETP Inc. generates 0.04x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - RegenETP Inc. is currently not profitable relative to its asset base.
RegenETP Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.11 | 6.52 | 6.52 |
| Quick Ratio | 4.11 | 6.52 | 6.52 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $6.75 Million | $ 19.39 Million | $ 19.39 Million |
RegenETP Inc. - Advanced Valuation Insights
This section examines the relationship between RegenETP Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.09 |
| Latest Market Cap to Assets Ratio | 0.05 |
| Asset Growth Rate (YoY) | -26.7% |
| Total Assets | $22.85 Million |
| Market Capitalization | $1.11 Million USD |
Valuation Analysis
Below Book Valuation: The market values RegenETP Inc.'s assets below their book value (0.05 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: RegenETP Inc.'s assets decreased by 26.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for RegenETP Inc. (2019–2022)
The table below shows the annual total assets of RegenETP Inc. from 2019 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | $22.85 Million | -26.72% |
| 2021-12-31 | $31.18 Million | -31.49% |
| 2020-12-31 | $45.51 Million | -15.09% |
| 2019-12-31 | $53.60 Million | -- |